Wound Care (Pharmacies) - New Zealand

Revenue in the Wound Care market is projected to reach US$4.25m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.24%, resulting in a market volume of US$4.30m by 2029.
In global comparison, most revenue will be generated United States (US$1.04bn in 2024).
In relation to total population figures, per person revenues of US$0.81 are generated in 2024.

Definition:
The Wound Care market consists of a comprehensive array of over-the-counter (OTC) solutions available for purchase through pharmacies. These solutions are aimed at managing wounds, promoting healing, and preventing infections. The product offerings encompass adhesive bandages for minor wound coverage, first aid kits providing extensive supplies, gauze and tape for maintaining cleanliness, as well as wound healing ointments that support the recovery of damaged skin and wounds. This market exclusively covers product sales through pharmacies.

Additional information:
The Wound Care market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Plasters
Adhesive Bandages
First Aid Kits
Gauze
Healing Ointment

Anti-Foot Blister Products
Wound Closure Devices, which require professional application
Prescription Wound Treatments

The Wound Care (Pharmacies) market in New Zealand has been experiencing steady growth in recent years.

Customer preferences: Customers in New Zealand have shown a growing preference for wound care products that are convenient and easy to use. This includes products such as adhesive bandages, wound dressings, and antiseptic creams. There is also a growing demand for advanced wound care products that promote faster healing and reduce the risk of infection. Customers are looking for products that are effective, affordable, and easily accessible.

Trends in the market: One of the key trends in the Wound Care (Pharmacies) market in New Zealand is the increasing adoption of online shopping. Customers are now able to purchase wound care products from the comfort of their own homes, which has led to a significant increase in online sales. This trend is driven by factors such as convenience, wider product selection, and competitive pricing. Pharmacies in New Zealand are also expanding their online presence to cater to this growing demand. Another trend in the market is the focus on natural and organic wound care products. Customers are becoming more conscious about the ingredients used in the products they use, and are opting for products that are free from harmful chemicals and additives. This trend is in line with the overall global shift towards natural and organic products, and is expected to continue driving the growth of the market in New Zealand.

Local special circumstances: New Zealand has a high rate of outdoor activities and sports participation, which increases the risk of injuries and wounds. This creates a constant demand for wound care products in the market. Additionally, the country has a growing aging population, which is more prone to chronic wounds and requires specialized wound care products. These local special circumstances contribute to the steady growth of the Wound Care (Pharmacies) market in New Zealand.

Underlying macroeconomic factors: The overall stability of the New Zealand economy has played a significant role in the growth of the Wound Care (Pharmacies) market. The country has experienced consistent economic growth, which has resulted in increased disposable income and higher healthcare spending. This has allowed customers to afford and prioritize wound care products. Furthermore, the government's focus on improving healthcare infrastructure and services has also contributed to the growth of the market. In conclusion, the Wound Care (Pharmacies) market in New Zealand is developing due to customer preferences for convenient and effective products, the increasing adoption of online shopping, the demand for natural and organic products, local special circumstances such as outdoor activities and an aging population, and the overall stability of the New Zealand economy.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.